News from Cochrane

Help us choose the content for our new online learning module about consumer involvement in Cochrane
We have a new Cochrane online learning module in development, and we’d like to invite you to help us think about what it might look like.

Background to the project

Last year Cochrane launched its Evidence Essentials learning resource covering topics such as an introduction to Evidence Based Medicine, clinical trials, evidence synthesis and how to use evidence in shared decision making. Cochrane is extending this resource with a fifth module which will include resources and information to help people learn more about being involved in all aspects of producing Cochrane evidence, and getting more involved in Cochrane generally.

Crowe Associates (Sally Crowe, and Lynn Laidlaw) are facilitating this process with staff from Cochrane’s People Services Department (Richard Morley, Consumer Engagement Officer, and Oliver Willis, Project Support & Administrator) and we look forward to working with a small group of people to develop module content.
Click to expand...
https://taskexchange.cochrane.org/tasks/1865
 
Registration is now open for ‘Virtually Cochrane’, an online event for all those involved with, or interested in, planning, doing, sharing and using health and healthcare evidence.

Early bird registration has been extended to 7 April 2021.

We welcome you to join us for a series of sessions on the theme of ‘navigating evidence and uncertainty’. Join live sessions or watch content on-demand. There will also be opportunities for networking, and access to a project hub.

Click on the links below to find out more about each session. View Frequently Asked Questions (FAQs) about the event.

https://uk.cochrane.org/our-work/upcoming-event-virtually-cochrane-2021/virtually-cochrane-programme

Click to expand...
 
Who's attending?

Registration free for patients/carers/advocates.

ETA: I've registered
 
Last edited:
upload_2021-5-9_11-54-37.png

eta:
the
value of cochrane
what it has done remains i think
extraordinary i personally am a keen
supporter of cochrane
but i'm a keen supporter of other
evidence collectors i'm a really keen
supporter of evidence-based practice
a massive supporter of evidence
synthesis that lands at the right time
to influence decisions and change the
course of people's health in that
respect i regard this work that i'm
doing
with you cochrane um as very much part
of my mission as a public health
physician
Click to expand...
 
Major milestones and new beginnings: Cochrane announces first round of new Thematic Groups

Cochrane is closing out a year of significant change and challenges with positive news of a major milestone in our transition to a more streamlined and sustainable organization. Following an open and rigorous application process, we are pleased to announce the first set of pilot Cochrane Thematic Groups – each mapping to key areas of global health and social care.

The Cochrane Thematic Groups are:

  • Global Ageing
  • Health Equity
  • Nutrition and Physical Activity
  • Person-Centred Care, Public Health and Health Systems
  • Sexual and Reproductive Health
  • Vascular
  • Work and Health and Social Security
"The concept of Thematic Groups was developed at a grass roots level during last year’s community consultation process," explains Cochrane’s Editor in Chief, Karla Soares-Weiser. "The creation and remit of these new groups reflects the clear community consensus that our specialist content and methods experts must have a central role and home within our new production model."
Click to expand...
To keep the community up to date with these and other developments, an updated Future Cochrane site will be launched in mid-December.
Click to expand...
https://community.cochrane.org/news...ane-announces-first-round-new-thematic-groups

so they can organise/set up all this lot.......
yet we still don't know which 'group' ME/CFS are being reassigned to.....then there's the 3 year wait for the re-writing/ updating or whatever of the exercise review.

"new production model."

THE FUTURE OF COCHRANE EVIDENCE SYNTHESIS
The case for vital transformation in a rapidly changing world
Case presented by Karla Soares-Weiser, Cochrane's Editor in Chief, for consideration on 9th February 2022 Board meeting and adapted to include and reflect the approved option.

The proposal was developed and endorsed by Cochrane's Executive Leadership Team and senior team members of the Evidence Production & Methods Directorate.
Click to expand...
 
Last edited by a moderator:
Moved posts



Cochrane UK on Twitter: "We are sorry to announce that Cochrane UK, based in Oxford, will close at the end of March 2024 with the end of National Institute for Health and Care Research (NIHR) funding: https://buff.ly/47325lx"

Article ends with: "The Cochrane UK team will continue to deliver on our current work programme until the end of the contract."
 
Last edited by a moderator:
The statement in the article is a piece from last week.

It says: "In March 2024, Cochrane UK’s current contract with National Institute for Health and Care Research (NIHR), hosted by the Oxford University Hospitals NHS Foundation Trust, will come to an end. As a result, Cochrane UK will shortly be seeking a new funder and host institution."

And: “As we look to the future, there is an exciting opportunity for a new institution to host Cochrane UK and help more people to benefit from health and care evidence. We will be reviewing what is needed in the UK before we begin a selection process. But I would encourage anyone interested in hosting Cochrane UK at their institution to get in touch with me in the meantime.”

Martin Burton [the departing Cochrane UK director] said: "Cochrane UK is in safe hands and I look forward to hearing more about Cochrane’s future plans."

Edited to add, ps: I'm sorry if this is in a wrong Cochrane thread. I thought it might apply here, but I could be mistaken.
 
Arvo said:
Moved posts



Cochrane UK on Twitter: "We are sorry to announce that Cochrane UK, based in Oxford, will close at the end of March 2024 with the end of National Institute for Health and Care Research (NIHR) funding: https://buff.ly/47325lx"

Article ends with: "The Cochrane UK team will continue to deliver on our current work programme until the end of the contract."
Click to expand...

Unfortunately:
Important to clarify: @CochraneUK is a regional centre within @cochranecollab, supporting Cochrane activities in the UK. The funding of Cochrane is not affected by this news.
Click to expand...
So sadly this is not the good news it seemed at first. I hope this entire organization closes down soon. It's true that the world needs high-quality evidence, and Cochrane's business model is aligned exactly opposite to that.
 
It took 8 years or more for NIHR to realise that Cochrane was not a good use of UK taxpayer's money, giving them warning after warning after warning. I don't think the Cochrane Exercise for CFS review had anything to do with their decision (although it should have done). Just the general crapness of the "product".
 
https://uk.cochrane.org/news/cochrane-uk-oxford-close-end-march-2024

Cochrane UK in Oxford to close at the end of March 2024
Blue%20Textured-blue-painted-background-534129318_2125x1416.jpeg

We are sorry to announce that Cochrane UK, based in Oxford, will close at the end of March 2024 with the end of National Institute for Health and Care Research (NIHR) funding.

Since Cochrane UK was established - as the first Cochrane centre - it has delivered a varied programme of work. For example, providing training, events (including four Colloquia, the inaugural one in Oxford, then Dublin and Edinburgh, with a fourth planned in London in September 2023) and resources for Cochrane contributors and others; supporting the dissemination of Cochrane evidence; and monitoring the impact of Cochrane Reviews.

In the early years, Cochrane UK conducted a programme of methods research and helped establish the Cochrane Central Register of Studies. Cochrane UK also founded Students 4 Best Evidence, a global network for students interested in evidence-based health care and carries out outreach work teaching school children, and others, about evidence-based decision-making.

The Cochrane UK team will continue to deliver on our current work programme until the end of the contract.

Important note: Cochrane UK is a regional centre within Cochrane, supporting Cochrane activities in the UK. The funding of Cochrane is not affected by this news - Cochrane will continue to produce Cochrane Reviews.
 
I was interested to see that Gillian Leng, previously the leader of NICE and under whose watch the 2021 ME/CFS Guideline was written, is a member of the Cochrane Governing Board.

Gillian Leng, CBE, MBChB, MD, is a professor of public health with a wealth of experience in healthcare and guideline development. She was on the Board of the National Institute for Health and Care Excellence (NICE) for over 20 years (2001-2021) most recently as its Chief Executive. As NICE’s Chief Executive, Gillian was responsible for delivering a new 5-year strategy to put NICE at the forefront of evidence-based evaluation of new technologies. This was underpinned by a vision for creating dynamic living guidelines for frontline healthcare staff. Prior to this, Gillian was instrumental in establishing the original clinical guideline programme at NICE, followed by setting up an implementation work programme to ensure the recommendations changed practice. She was involved with the Cochrane Collaboration from its inception and for many years as a reviewer and an editor.

With a passion for using evidence to improve healthcare, Gillian is a member of the Global Evidence Commission. She is a visiting professor at King’s College London, an affiliate professor at the University of Singapore. Gillian read medicine at the University of Leeds, and is a fellow of the Royal Colleges of Physicians in London and Edinburgh. She was awarded an honorary degree of Doctor of Science by the University of Leeds in 2022, and a CBE in 2012 for services to healthcare.
Click to expand...
 
Last edited:
You must log in or register to reply here.
Back
Top Bottom